NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress
Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress
Read More
Tag: diabetes distress
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
